Tradestie Institutional Equity Comparison Engine

BHVN vs ADPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADPT Overall Edge

ADPT Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Momentum & Technical, Options & Structure while BHVN counters with relative strength in Growth & Margin. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BHVN N/M vs ADPT N/M Fwd P/E
Growth & Margin Winner BHVN
Op Margin 0.0% vs -16.2% ยท YoY +0.0% vs -10.7%
Momentum & Technical Winner ADPT
1Y +72.1% vs +98.0% ยท 52W Pos 59% vs 79%
Options & Structure Winner ADPT
CONSOLIDATION (18th %ile IV) vs CONSOLIDATION (32nd %ile IV)
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.90
+0.62% 1D
Market Cap $2.1B
1M Return +28.99%
1Y Return +72.09%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$28.00
-3.58% 1D
Market Cap $4.7B
1M Return +16.57%
1Y Return +98.02%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 43.0 Flow 69.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHVN +72.09% ADPT +98.02% Spread: +25.93 pp (ADPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHVN TTM Op. Margin: 0.0% ADPT TTM Op. Margin: -16.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHVN vs ADPT. Trailing 12-month operating profitability (BHVN 0.0% vs ADPT -16.2%) and valuation multiples (BHVN N/M vs ADPT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHVN (3) vs ADPT (5)
Institutional Metric BHVN ADPT Criterion Row Winner
Market Capitalization Scale $2.1B $4.7B Larger Scale ADPT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -10.7% Higher Growth BHVN
Operating Margin (TTM) Profitability 0.0% -16.2% Higher Margin BHVN
Net Profit Margin Profitability 0.0% -23.7% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -799.5% -36.4% Higher ROE ADPT
52-Week Range Position Momentum 59% ($8โ€“$18) 79% ($12โ€“$32) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 1.41ฮฒ ยท 111% Vol 1.75ฮฒ ยท 60% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite ADPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHVN vs ADPT Buy Guide
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADPT CONSOLIDATION
69d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHVN nor ADPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.